Clinical Trial Update: A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase II study evaluating SSGJ-706 as monotherapy and in combination for first-line advanced non-small cell lung cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• SSGJ-706 (SSGJ-706)

Snippet

Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. | Conditions: First-line Advanced NSCLC Patients | Phase 2 | Status: RECRUITING